(Total Views: 511)
Posted On: 05/06/2025 3:13:46 AM
Post# of 153277
Great post, MGK. Not a single military metaphor, even. So, for the general audience here, both of those quotes are from Cytodyn's clinical findings (from 2022?) in treatment of six CRC patients, and the second quote in your post concerns a single patient, not the group. Do I have this right?
Given that "one of them actually had no measurable lesions on the PET scan at follow-up. And the remainder saw either stable disease or partial responses," what would be your guess about "Survival," since that is the topic of the paper to be presented in Barca? Certainly one. Maybe one to three out of six?
God knows it would have been nice to have all of them CONTINUE on Leron instead of just being treated during the short study. We can imagine the great results if they had.
Given that "one of them actually had no measurable lesions on the PET scan at follow-up. And the remainder saw either stable disease or partial responses," what would be your guess about "Survival," since that is the topic of the paper to be presented in Barca? Certainly one. Maybe one to three out of six?
God knows it would have been nice to have all of them CONTINUE on Leron instead of just being treated during the short study. We can imagine the great results if they had.
(7)
(0)Scroll down for more posts ▼
